IMS® DIAREG Diabetes Registry - Prospective Diabetes Registry of Patients With Type 2 Diabetes Mellitus

IMS Health

Status: Terminated

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: antidiabetic treatment (ATC A10B)

Study type: Observational

Funder types: Industry

Identifiers

NCT01906294

5050000

Details and patient eligibility

About

This observation plan outlines the approach to build a diabetes registry to collect data on daily routine of treatment of Type 2 Diabetes Mellitus.

Full description

The choice to establish such a (general and specific) disease patient registry was based on several scientific and practical considerations as described in the AHRQ user's guide: registries for evaluating patient outcomes (www.ahrq.gov, 2007). From a public health point of view, such a register should monitor naturalistic (i.e., unbiased) use of diabetes treatment in the community and should primarily guide and assist medical professionals to make optimal choices in combating diabetes. The primary focus of this registry is therefore to monitor the medical and lifestyle treatment of diabetes in order to enable comparison of different treatment options and to provide data for future discussions of optimal treatment.

Enrollment: 2,104 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Provision of signed written informed consent
• Age of 18 years or older
• Diagnosis of Type 2 Diabetes Mellitus (T2DM)

Exclusion criteria

Only patients who don't fulfill the inclusion criteria will be excluded. There will be no further possibility for the treating physician to exclude individual patients.

Trial design

2,104 participants in 1 patient group

Type 2 Diabetes Mellitus

Description:

Patients with antidiabetic treatment for Type 2 Diabetes Mellitus

Treatment:

Drug: antidiabetic treatment (ATC A10B)